Thioredoxin reductase was nitrated in the aging heart after myocardial ischemia/reperfusion

Rejuvenation Research

Volumn 16, Issue 5, 2013, Pages 377-385

  Wang, Ke ^a   Zhang, Jie ^b   Wang, Xiaoliang ^c   Liu, Xin ^a   Zuo, Lin ^b   Bai, Kehua ^a   Shang, Jianyu ^a   Ma, Lu ^a   Liu, Teng ^a   Wang, Li ^b   Wang, Wen ^a   Ma, Xinliang ^c   Liu, Huirong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MALONALDEHYDE; NITRIC OXIDE; NITROGEN OXIDE; PEROXYNITRITE; THIOREDOXIN; THIOREDOXIN REDUCTASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; BIOCATALYSIS; CARDIOTONIC AGENTS; ENZYME ACTIVATION; MALE; METALLOPORPHYRINS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITROSATION; PEROXYNITROUS ACID; RATS; RATS, SPRAGUE-DAWLEY; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 84886075814     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2013.1437     Document Type: Article

References (30)

1. Lakatta EG, Levy D. Arterial and cardiac aging: Major hareholders in cardiovascular disease enterprises: Part I: Aging arteries: A "set up" for vascular disease. Circulation 2003; 107:139-146. (Pubitemid 36070946)
2. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with aging. Cardiovasc Res 2009;83:247-261.
3. Lesnefsky EJ, Hoppel CL. Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat. Biochim Biophys Acta 2008;1777:1020-1027.
4. Ugarte N, Petropoulos I, Friguet B. Oxidized mitochondrial protein degradation and repair in aging and oxidative stress. Antioxid Redox Signal 2010;13:539-549.
5. Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol 2008;101:14D-19D.
6. Fan Q, Chen M, Fang X, Lau WB, Xue L, Zhao L, Zhang H, Liang YH, Bai X, Niu HY, Ye J, Chen Q, Yang X, Liu M. Aging might augment reactive oxygen species (ROS) formation and affect reactive nitrogen species (RNS) level after myocardial ischemia/reperfusion in both humans and rats. Age (Dordr) 2012; doi 10.1007/s11357-012-9421-y.
7. Ji L, Fu F, Zhang L, Liu W, Cai X, Zhang L, Zheng Q, Zhang H, Gao F. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab 2010;298:E871-E880.
8. Berndt C, Lillig CH, Holmgren A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: Implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol 2007;292:H1227-H1236. (Pubitemid 46377107)
9. Zhang H, Tao L, Jiao X, Gao E, Lopez BL, Christopher TA, Koch W, Ma XL. Nitrative thioredoxin inactivation as a cause of enhanced myocardial ischemia/reperfusion injury in the aging heart. Free Radic Biol Med 2007;43:39-47. (Pubitemid 46874836)
10. Monteiro HP, Arai RJ, Travassos LR. Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antioxid Redox Signal 2008;10:843-889. (Pubitemid 351301369)
11. Horstkotte J, Perisic T, Schneider M, Lange P, Schroeder M, Kiermayer C, Hinkel R, Ziegler T, Mandal PK, David R, Schulz S, Schmitt S, Widder J, Sinowatz F, Becker BF, Bauersachs J, Naebauer M, Franz WM, Jeremias I, Brielmeier M, Zischka H, Conrad M, Kupatt C. Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection. Circulation 2011;124:2892-2902.
12. Sibbing D, Pfeufer A, Perisic T, Mannes AM, Fritz-Wolf K, Unwin S, Sinner MF, Gieger C, Gloeckner CJ, Wichmann HE, Kremmer E, Schäfer Z, Walch A, Hinterseer M, Näbauer M, Kääb S, Kastrati A, Schömig A, Meitinger T, Bornkamm GW, Conrad M, von Beckerath N. Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J 2011;32:1121-1133.
13. Rohrbach S, Gruenler S, Teschner M, Holtz J. The thioredoxin system in aging muscle: key role of mitochondrial thioredoxin reductase in the protective effects of caloric restriction? Am J Physiol Regul Integr Comp Physiol 2006; 291:R927-R935. (Pubitemid 44498432)
14. Myers JM, Antholine WE, Myers CR. The intracellular redox stress caused by hexavalent chromium is selective for proteins that have key roles in cell survival and thiol redox control. Toxicology 2011;281:37-47.
15. Myers JM, Myers CR. The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells. Free Radic Biol Med 2009;47: 1477-1485.
16. Vadseth C, Souza JM, Thomson L, Seagraves A, Nagaswami C, Scheiner T, Torbet J, Vilaire G, Bennett JS, Murciano JC, Muzykantov V, Penn MS, Hazen SL, Weisel JW, Ischiropoulos H. Prothrombotic state induced by post- translationalmodification of fibrinogen by reactive nitrogen species. J Biol Chem 2004;279:8820-8826. (Pubitemid 38295940)
17. Wang K, Zhang J, Liu J, Tian J, Wu Y, Wang X, Quan L, Xu H, Wang W, Liu H. Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death: Omi/HtrA2 and aged heart injury. Age (Dordr) 2013;35:733-746.
18. Lillig CH, Holmgren A. Thioredoxin and related molecules-from biology to health and disease. Antioxid Redox Signal 2007;9:25-47. (Pubitemid 44901873)
19. Sartoretto JL, Jin BY, Bauer M, Gertler FB, Liao R, Michel T. Regulation of VASP phosphorylation in cardiac myocytes: Differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart. Am J Physiol Heart Circ Physiol 2009;297:H1697-H1710.
20. Chen H, Yu M, Li M, Zhao R, Zhu Q, Zhou W, Lu M, Lu Y, Zheng T, Jiang J, Zhao W, Xiang K, Jia W, Liu L. Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease. Mol Cell Biochem 2012;363:85-91.
21. Holmgren A, Lu J. Thioredoxin and thioredoxin reductase: Current research with special reference to human disease. Biochem Biophys Res Commun 2010;396:120-124.
22. Witte AB, Anestål K, Jerremalm E, Ehrsson H, Arnér ES. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinumcontaining anticancer compounds. Free Radic Biol Med 2005; 239:696-703. (Pubitemid 41112110)
23. Xing KY, Lou MF. Effect of age on the thioltransferase (glutaredoxin) and thioredoxin systems in the human lens. Invest Ophthalmol Vis Sci 2010;51:6598-6604.
24. Xia L, Nordman T, Olsson JM, Damdimopoulos A, Björkhem-Bergman L, Nalvarte I, Eriksson LC, Arnér ES, Spyrou G, Björnstedt M. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J Biol Chem 2003;278: 2141-2146. (Pubitemid 36801279)
25. Sandalova T, Zhong L, Lindqvist Y, Holmgren A, Schneider G. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci USA 2001;98:9533-9538. (Pubitemid 32769338)
26. Haendeler J. Thioredoxin-1 and posttranslational modifications. Antioxid Redox Signal 2006;8:1723-1728. (Pubitemid 44726344)
27. Tao L, Jiao X, Gao E, Lau WB, Yuan Y, Lopez B, Christopher T, Ramachandrarao SP, Williams W, Southan G, Sharma K, Koch W, Ma XL. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 2006;114:1395-1402. (Pubitemid 44454559)
28. Cernadas MR, Sánchez de Miguel L, García-Durán M, González-Fernández F, Millás I, Montón M, Rodrigo J, Rico L, Fernández P, de Frutos T, Rodríguez-Feo JA, Guerra J, Caramelo C, Casado S, López-Farré. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 1998;83:279-286. (Pubitemid 28371317)
29. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 2003;138:532-543. (Pubitemid 36315301)
30. Li D, Qu Y, Tao L, Liu H, Hu A, Gao F, Sharifi-Azad S, Grunwald Z, Ma XL, Sun JZ. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. J Surg Res 2006;131:64-72. (Pubitemid 43227585)